“…Additionally, our analyses could confirm many associations previously reported in the microbiome of IBD patients, such as the mucus-degrading Akermansia muciniphila, Alistipes spp., the Prevotella copri complex , Gemmiger spp., and Methanobrevibacter A smithii (Vich Vila et al, 2018). The methanoarchaeon M. smithii is a known marker of healthy anaerobic gut microbiomes, as demonstrated by several studies focusing on the evolution of mammalian gut microbiomes (Rühlemann et al, 2023). By producing methane as a metabolic product in anoxic conditions through the fermentation of bacterial primary products, such as acetate, methanol, hydrogen and carbon dioxide (Thauer, 1998; Thauer & Shima, 2006), it can engage in syntrophic interactions with a broad range of bacteria (Samuel et al, 2007; Samuel & Gordon, 2006).…”